or Try an Advanced Search...

    Technical Analysis for HLS - HLS Therapeutics Inc

    Grade Last Price % Change Price Change
    D 3.420 3.32% 0.110
    HLS closed up 3.32 percent on Friday, November 22, 2024, on 62 percent of normal volume. It ran into resistance at its 50 day moving average.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Up
    Historical HLS trend table...
    Date Alert Name Type % Chg
    50 DMA Resistance Bearish 0.00%
    Crossed Above 20 DMA Bullish 0.00%
    New Uptrend Bullish 0.00%
    Oversold Stochastic Weakness 0.00%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 3.32%
    Gapped Up Strength 3.32%
    Oversold Stochastic Weakness 3.32%
    180 Bearish Setup Bearish Swing Setup 9.27%
    Volume Surge Other 9.27%
    Outside Day Range Expansion 9.27%
    Older End-of-Day Signals for HLS ...

       Recent Intraday Alerts

    Alert Time
    50 DMA Resistance 2 days ago
    Up 1 ATR 2 days ago
    Up 5% 2 days ago
    Up 3% 2 days ago
    Rose Above Previous Day's High 2 days ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    HLS Chart by TradingView
    Basic chart:

    Profile

    HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. Its lead product is Clozaril, an atypical antipsychotic used in the treatment of schizophrenia. The company also holds the U.S. marketing rights of Absorica, a commercial stage dermatology product. HLS Therapeutics Inc. has a license agreement with Amarin Corporation plc to register, commercialize, and distribute Vascepa capsules in Canada. The company was founded in 2018 and is headquartered in Toronto, Canada.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Pharmaceutical Life Sciences Pharmaceutical Products

    Is HLS a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.48
    52 Week Low 3.0
    Average Volume 31,331
    200-Day Moving Average 3.767
    50-Day Moving Average 3.532
    20-Day Moving Average 3.374
    10-Day Moving Average 3.314
    Average True Range 0.188
    RSI (14) 49.75
    ADX 26.02
    +DI 24.441
    -DI 23.683
    Chandelier Exit (Long, 3 ATRs) 3.337
    Chandelier Exit (Short, 3 ATRs) 3.563
    Upper Bollinger Bands 3.693
    Lower Bollinger Band 3.055
    Percent B (%b) 0.57
    BandWidth 18.892
    MACD Line -0.086
    MACD Signal Line -0.078
    MACD Histogram -0.0075
    Fundamentals Value
    Market Cap 108.83 Million
    Num Shares 31.8 Million
    EPS -0.90
    Price-to-Earnings (P/E) Ratio -3.81
    Price-to-Sales 8.55
    Price-to-Book 2.89
    Dividend 0.16
    Dividend Yield 4.68%
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.795
    Resistance 3 (R3) 3.797 3.673 3.733
    Resistance 2 (R2) 3.673 3.578 3.673 3.712
    Resistance 1 (R1) 3.547 3.519 3.610 3.545 3.691
    Pivot Point 3.423 3.423 3.455 3.423 3.423
    Support 1 (S1) 3.297 3.328 3.360 3.295 3.149
    Support 2 (S2) 3.173 3.269 3.173 3.128
    Support 3 (S3) 3.047 3.173 3.108
    Support 4 (S4) 3.045